METOPROLOL SUCCINATE

METOPROLOL SUCCINATE was reported 88249 times

METOPROLOL SUCCINATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SUSPECTED SUICIDE 375 0.0799
1 BRASH SYNDROME 111 0.0791
2 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 79 0.0744
3 ESSENTIAL HYPERTENSION 136 0.0742
4 NEPHROGENIC ANAEMIA 275 0.0593
5 HYPERPARATHYROIDISM SECONDARY 146 0.0582
6 AORTIC VALVE STENOSIS 76 0.0426
7 OBSTRUCTIVE SLEEP APNOEA SYNDROME 59 0.0404
8 REBOUND ACID HYPERSECRETION 113 0.0373
9 INFUSION SITE DISCHARGE 62 0.0353
10 HAEMORRHAGIC ANAEMIA 155 0.0352
11 EYELID PAIN 70 0.0344
12 BLOOD PRESSURE INADEQUATELY CONTROLLED 203 0.0337
13 TACHYARRHYTHMIA 82 0.0328
14 AORTIC ARTERIOSCLEROSIS 79 0.0307
15 CORONARY ARTERIAL STENT INSERTION 151 0.0298
16 CORONARY ARTERY DISEASE 857 0.0283
17 END STAGE RENAL DISEASE 510 0.0279
18 DIASTOLIC DYSFUNCTION 86 0.0278
19 ARTERIOSCLEROSIS CORONARY ARTERY 183 0.0276
20 DIVERTICULUM INTESTINAL 120 0.0274
21 ANGINA UNSTABLE 178 0.0274
22 BLOOD LOSS ANAEMIA 61 0.0269
23 INFUSION SITE HAEMORRHAGE 88 0.0267
24 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 65 0.0263
25 ATRIAL FLUTTER 208 0.0260
26 HEPATIC CYST 88 0.0259
27 PRODUCT ADMINISTRATION INTERRUPTED 200 0.0255
28 CORONARY ARTERY BYPASS 146 0.0254
29 CHRONIC GASTRITIS 56 0.0248
30 ISCHAEMIC CARDIOMYOPATHY 73 0.0238
31 BODY HEIGHT DECREASED 254 0.0237
32 SEASONAL ALLERGY 336 0.0237
33 AORTIC STENOSIS 82 0.0235
34 OXYGEN CONSUMPTION INCREASED 54 0.0226
35 CORONARY ARTERY OCCLUSION 305 0.0222
36 ATRIAL FIBRILLATION 2161 0.0222
37 VENTRICULAR EXTRASYSTOLES 230 0.0221
38 PRE-EXISTING CONDITION IMPROVED 137 0.0219
39 HIATUS HERNIA 280 0.0216
40 HIGH DENSITY LIPOPROTEIN DECREASED 70 0.0210
41 CORONARY ARTERY STENOSIS 104 0.0207
42 TRICUSPID VALVE INCOMPETENCE 163 0.0205
43 HEART RATE ABNORMAL 113 0.0202
44 SINUS BRADYCARDIA 195 0.0202
45 MITRAL VALVE INCOMPETENCE 224 0.0198
46 EXTRASYSTOLES 138 0.0197
47 LOWER GASTROINTESTINAL HAEMORRHAGE 145 0.0196
48 HYPERLIPIDAEMIA 234 0.0196
49 LEFT VENTRICULAR DYSFUNCTION 131 0.0195
50 VASCULAR GRAFT 56 0.0194
51 INFUSION SITE SWELLING 122 0.0194
52 BUNDLE BRANCH BLOCK LEFT 82 0.0193
53 BLOOD CHOLESTEROL ABNORMAL 88 0.0190
54 AORTIC VALVE INCOMPETENCE 81 0.0190
55 CHRONIC KIDNEY DISEASE 1446 0.0190
56 STENT PLACEMENT 152 0.0188
57 CARDIAC FAILURE CONGESTIVE 1497 0.0186
58 CARDIOGENIC SHOCK 266 0.0185
59 INFUSION SITE ERYTHEMA 155 0.0184
60 HYPERVOLAEMIA 90 0.0182
61 ACUTE MYOCARDIAL INFARCTION 537 0.0182
62 CAROTID ARTERY STENOSIS 63 0.0180
63 ATRIOVENTRICULAR BLOCK FIRST DEGREE 78 0.0180
64 BLOOD PRESSURE ABNORMAL 357 0.0179
65 CARDIAC FLUTTER 116 0.0179
66 ATRIOVENTRICULAR BLOCK SECOND DEGREE 54 0.0178
67 SUPRAVENTRICULAR EXTRASYSTOLES 60 0.0177
68 VENTRICULAR HYPOKINESIA 57 0.0177
69 CARDIAC FAILURE ACUTE 118 0.0177
70 DIABETIC NEUROPATHY 87 0.0176
71 HEART RATE IRREGULAR 397 0.0176
72 INFUSION SITE PAIN 225 0.0174
73 INFUSION SITE PRURITUS 55 0.0174
74 GOUT 312 0.0174
75 RENAL CYST 138 0.0174
76 CARDIAC FAILURE CHRONIC 74 0.0173
77 SPINAL OSTEOARTHRITIS 150 0.0171
78 DYSPNOEA EXERTIONAL 639 0.0169
79 ANXIETY DISORDER 56 0.0167
80 HYPERURICAEMIA 68 0.0165
81 VITAMIN D DEFICIENCY 158 0.0162
82 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 66 0.0161
83 VENTRICULAR ARRHYTHMIA 59 0.0161
84 SUPRAVENTRICULAR TACHYCARDIA 154 0.0161
85 CATHETERISATION CARDIAC 71 0.0160
86 DIZZINESS POSTURAL 155 0.0160
87 LEFT VENTRICULAR FAILURE 55 0.0160
88 SNORING 60 0.0159
89 BLOOD MAGNESIUM DECREASED 136 0.0157
90 HYPERCHOLESTEROLAEMIA 152 0.0157
91 ARTERIOSCLEROSIS 148 0.0157
92 PERIPHERAL VASCULAR DISORDER 81 0.0157
93 MULTIPLE ALLERGIES 123 0.0157
94 SKIN ABRASION 74 0.0156
95 HAEMOGLOBIN INCREASED 71 0.0155
96 PROSTATOMEGALY 61 0.0155
97 ATRIOVENTRICULAR BLOCK 120 0.0155
98 INCREASED TENDENCY TO BRUISE 142 0.0154
99 ANGINA PECTORIS 441 0.0154
100 EJECTION FRACTION DECREASED 239 0.0154
101 BENIGN PROSTATIC HYPERPLASIA 79 0.0153
102 LEFT VENTRICULAR HYPERTROPHY 65 0.0152
103 ARTERIAL OCCLUSIVE DISEASE 119 0.0151
104 HYPOVOLAEMIA 88 0.0150
105 ACUTE RESPIRATORY FAILURE 285 0.0148
106 RHINITIS ALLERGIC 65 0.0146
107 VENTRICULAR TACHYCARDIA 238 0.0144
108 INTERVERTEBRAL DISC DEGENERATION 133 0.0144
109 SLEEP APNOEA SYNDROME 274 0.0143
110 ATRIOVENTRICULAR BLOCK COMPLETE 96 0.0143
111 HAEMORRHOIDAL HAEMORRHAGE 70 0.0143
112 ARRHYTHMIA 678 0.0143
113 PULMONARY HYPERTENSION 298 0.0143
114 DIVERTICULUM 101 0.0142
115 TRIGGER FINGER 58 0.0142
116 CHRONIC SINUSITIS 53 0.0141
117 CARDIAC PACEMAKER INSERTION 84 0.0141
118 EYE PAIN 793 0.0140
119 RENAL FAILURE CHRONIC 108 0.0140
120 HYPOMAGNESAEMIA 193 0.0138
121 GASTROINTESTINAL HAEMORRHAGE 1152 0.0138
122 HYPERTENSIVE CRISIS 152 0.0136
123 FOREIGN BODY SENSATION IN EYES 87 0.0136
124 PELVIC FRACTURE 106 0.0136
125 UPPER-AIRWAY COUGH SYNDROME 112 0.0136
126 TROPONIN INCREASED 103 0.0135
127 CARDIAC VALVE DISEASE 77 0.0135
128 HEART RATE DECREASED 473 0.0135
129 GLOMERULAR FILTRATION RATE DECREASED 165 0.0134
130 CARDIOMYOPATHY 198 0.0134
131 PROTHROMBIN TIME PROLONGED 80 0.0134
132 MYOCARDIAL ISCHAEMIA 152 0.0133
133 INTERNATIONAL NORMALISED RATIO DECREASED 54 0.0133
134 CARDIOMEGALY 164 0.0133
135 SPINAL STENOSIS 55 0.0133
136 FULL BLOOD COUNT DECREASED 268 0.0133
137 MYOCARDIAL INFARCTION 2319 0.0133
138 SCOLIOSIS 82 0.0132
139 UPPER GASTROINTESTINAL HAEMORRHAGE 222 0.0132
140 GLUCOSE TOLERANCE IMPAIRED 78 0.0132
141 BUNDLE BRANCH BLOCK RIGHT 60 0.0131
142 NOCTURIA 157 0.0129
143 RENAL FUNCTION TEST ABNORMAL 60 0.0129
144 BLOOD PRESSURE FLUCTUATION 305 0.0127
145 BRADYCARDIA 672 0.0127
146 BLOOD POTASSIUM DECREASED 379 0.0126
147 RENAL INJURY 374 0.0126
148 BLOOD POTASSIUM INCREASED 203 0.0125
149 ANEURYSM 62 0.0124
150 GASTRITIS EROSIVE 58 0.0124
151 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 647 0.0124
152 CARDIAC MURMUR 107 0.0124
153 TORSADE DE POINTES 97 0.0124
154 ORTHOSTATIC HYPOTENSION 215 0.0123
155 INTERNAL HAEMORRHAGE 139 0.0122
156 BLOOD PRESSURE INCREASED 1849 0.0121
157 BLOOD UREA INCREASED 202 0.0121
158 WEIGHT FLUCTUATION 126 0.0120
159 PROTEIN URINE PRESENT 60 0.0120
160 OCULAR DISCOMFORT 135 0.0120
161 LARGE INTESTINE POLYP 83 0.0120
162 FLUID RETENTION 609 0.0120
163 AORTIC ANEURYSM 91 0.0119
164 OSTEOPENIA 181 0.0119
165 POLYP 78 0.0119
166 RALES 69 0.0119
167 HEART RATE INCREASED 1170 0.0118
168 CHOKING SENSATION 65 0.0118
169 RENAL FAILURE 1565 0.0118
170 GROIN PAIN 103 0.0117
171 ELECTROCARDIOGRAM ABNORMAL 92 0.0117
172 GASTROOESOPHAGEAL REFLUX DISEASE 943 0.0117
173 IRON DEFICIENCY ANAEMIA 108 0.0117
174 PRODUCTIVE COUGH 557 0.0117
175 HAEMOPTYSIS 325 0.0116
176 HYPERKALAEMIA 407 0.0116
177 PULMONARY CONGESTION 153 0.0116
178 BLOOD SODIUM DECREASED 218 0.0116
179 GASTRIC ULCER HAEMORRHAGE 64 0.0115
180 ATELECTASIS 111 0.0115
181 EPISTAXIS 858 0.0115
182 SPINAL COLUMN STENOSIS 54 0.0114
183 FAILURE TO THRIVE 59 0.0114
184 BREATH SOUNDS ABNORMAL 56 0.0113
185 ACUTE CORONARY SYNDROME 94 0.0113
186 VITAMIN D DECREASED 97 0.0113
187 ACUTE KIDNEY INJURY 1720 0.0112
188 PERIPHERAL COLDNESS 154 0.0112
189 HAEMATOCRIT DECREASED 222 0.0112
190 BACK DISORDER 182 0.0112
191 HYPERTENSION 2366 0.0112
192 HOSPICE CARE 110 0.0111
193 CARDIAC DISORDER 1038 0.0111
194 HYPOTENSION 2216 0.0110
195 NASAL DRYNESS 69 0.0110
196 PALPITATIONS 1289 0.0110
197 BLOOD CALCIUM DECREASED 123 0.0109
198 VENTRICULAR FIBRILLATION 121 0.0109
199 SINUS DISORDER 215 0.0108
200 DECREASED INTEREST 64 0.0108
201 TRANSIENT ISCHAEMIC ATTACK 366 0.0108
202 PHOTOPHOBIA 204 0.0108
203 VARICOSE VEIN 56 0.0108
204 DIVERTICULITIS 300 0.0108
205 EXERCISE TOLERANCE DECREASED 62 0.0108
206 RED BLOOD CELL COUNT DECREASED 307 0.0107
207 BLOOD PRESSURE DECREASED 710 0.0107
208 INTERNATIONAL NORMALISED RATIO INCREASED 303 0.0106
209 PULMONARY MASS 158 0.0106
210 PROSTATIC SPECIFIC ANTIGEN INCREASED 146 0.0106
211 FAECALOMA 58 0.0106
212 MENISCUS INJURY 65 0.0106
213 OXYGEN SATURATION DECREASED 594 0.0106
214 TASTE DISORDER 214 0.0105
215 SCIATICA 168 0.0105
216 POSTOPERATIVE WOUND INFECTION 71 0.0105
217 COAGULOPATHY 175 0.0105
218 LIMB INJURY 284 0.0104
219 CONTUSION 1005 0.0104
220 IMPAIRED GASTRIC EMPTYING 142 0.0104
221 JOINT DISLOCATION 110 0.0104
222 HYPOXIA 366 0.0104
223 HYPERKERATOSIS 57 0.0103
224 URINARY TRACT INFECTION 1757 0.0103
225 DECREASED ACTIVITY 111 0.0103
226 HEAD INJURY 325 0.0103
227 COMPRESSION FRACTURE 55 0.0103
228 PLEURAL EFFUSION 624 0.0102
229 PULMONARY OEDEMA 459 0.0102
230 CARDIAC OPERATION 88 0.0102
231 ROTATOR CUFF SYNDROME 131 0.0102
232 ONYCHOCLASIS 70 0.0102
233 CARDIAC FAILURE 814 0.0101
234 FLANK PAIN 95 0.0101
235 HAEMORRHAGIC STROKE 79 0.0101
236 OBESITY 161 0.0101
237 TUBULOINTERSTITIAL NEPHRITIS 189 0.0101
238 COLITIS ISCHAEMIC 68 0.0101
239 ECCHYMOSIS 69 0.0101
240 CHEST PAIN 1859 0.0100
241 PERICARDIAL EFFUSION 232 0.0100
242 WALKING AID USER 66 0.0100
243 LYMPHOEDEMA 69 0.0100
244 NEPHROPATHY 93 0.0100
245 EAR DISCOMFORT 102 0.0099
246 SINUS HEADACHE 59 0.0099
247 RIB FRACTURE 204 0.0099
248 SOMNAMBULISM 65 0.0099
249 INTERVERTEBRAL DISC PROTRUSION 216 0.0099
250 PERIPHERAL SWELLING 1521 0.0099
251 THYROID DISORDER 152 0.0099
252 HAEMOGLOBIN DECREASED 1012 0.0098
253 BLOOD TRIGLYCERIDES INCREASED 174 0.0098
254 BLOOD CHOLESTEROL INCREASED 458 0.0098
255 BLOOD CREATININE INCREASED 641 0.0098
256 DEHYDRATION 1308 0.0098
257 GASTROENTERITIS VIRAL 177 0.0098
258 HYPOKALAEMIA 450 0.0097
259 LUNG INFILTRATION 86 0.0097
260 SKIN ATROPHY 56 0.0097
261 SYNCOPE 973 0.0097
262 HAEMATURIA 333 0.0097
263 ERUCTATION 187 0.0097
264 HOT FLUSH 728 0.0096
265 SKIN LACERATION 105 0.0096
266 MALNUTRITION 108 0.0096
267 MENTAL STATUS CHANGES 268 0.0096
268 UROSEPSIS 89 0.0096
269 BLOOD IRON DECREASED 114 0.0096
270 PRODUCT DISTRIBUTION ISSUE 89 0.0096
271 PLATELET COUNT ABNORMAL 58 0.0096
272 WRIST FRACTURE 115 0.0096
273 MUSCULOSKELETAL DISCOMFORT 165 0.0096
274 BLOOD CALCIUM INCREASED 84 0.0096
275 COUGH 2676 0.0095
276 PRESYNCOPE 232 0.0095
277 FALL 3174 0.0095
278 BLOOD URINE PRESENT 181 0.0095
279 LACRIMATION INCREASED 288 0.0095
280 OESOPHAGITIS 104 0.0095
281 RESTLESS LEGS SYNDROME 173 0.0095
282 SINUS TACHYCARDIA 135 0.0095
283 HEPATIC STEATOSIS 177 0.0095
284 HYDRONEPHROSIS 71 0.0095
285 RENAL TUBULAR NECROSIS 93 0.0095
286 RETCHING 202 0.0095
287 BACK INJURY 103 0.0095
288 BRONCHITIS 701 0.0095
289 OEDEMA PERIPHERAL 1153 0.0094
290 POLLAKIURIA 393 0.0094
291 HAEMORRHOIDS 183 0.0094
292 SKIN HAEMORRHAGE 139 0.0094
293 RHINORRHOEA 605 0.0094
294 LEUKOCYTOSIS 169 0.0093
295 UPPER RESPIRATORY TRACT INFECTION 431 0.0093
296 HYPERSOMNIA 267 0.0093
297 ULCER HAEMORRHAGE 63 0.0093
298 OROPHARYNGEAL DISCOMFORT 84 0.0093
299 SKIN ULCER 240 0.0093
300 BOWEL MOVEMENT IRREGULARITY 71 0.0093
301 HEAD DISCOMFORT 164 0.0093
302 SMALL INTESTINAL OBSTRUCTION 114 0.0093
303 EYE IRRITATION 532 0.0092
304 APPETITE DISORDER 61 0.0092
305 OSTEOARTHRITIS 390 0.0092
306 URINE ODOUR ABNORMAL 54 0.0092
307 BLOOD URIC ACID INCREASED 53 0.0092
308 THROAT IRRITATION 411 0.0092
309 RIGHT VENTRICULAR FAILURE 64 0.0091
310 MACULAR DEGENERATION 109 0.0091
311 RESPIRATORY TRACT CONGESTION 145 0.0091
312 FOOT FRACTURE 173 0.0091
313 LIGAMENT SPRAIN 90 0.0091
314 RENAL FAILURE ACUTE 386 0.0091
315 CARPAL TUNNEL SYNDROME 127 0.0091
316 ANURIA 78 0.0091
317 BRAIN FOG 142 0.0091
318 IMPAIRED QUALITY OF LIFE 130 0.0090
319 HAND FRACTURE 64 0.0090
320 HAEMORRHAGE INTRACRANIAL 135 0.0090
321 GINGIVAL BLEEDING 123 0.0090
322 HEARING IMPAIRED 54 0.0090
323 MOUTH HAEMORRHAGE 66 0.0090
324 ESCHERICHIA INFECTION 74 0.0090
325 FAECES DISCOLOURED 195 0.0090
326 CYSTITIS 286 0.0090
327 DYSPNOEA 5066 0.0089
328 PSYCHOLOGICAL TRAUMA 77 0.0089
329 MUSCULOSKELETAL CHEST PAIN 138 0.0089
330 ASTHENIA 3348 0.0089
331 BALANCE DISORDER 769 0.0089
332 INSURANCE ISSUE 136 0.0089
333 ORAL PAIN 199 0.0089
334 NERVE COMPRESSION 82 0.0089
335 TYPE 2 DIABETES MELLITUS 299 0.0089
336 CONSTIPATION 1936 0.0089
337 ELECTROLYTE IMBALANCE 103 0.0089
338 PAIN IN JAW 251 0.0089
339 EYE DISCHARGE 92 0.0088
340 PRODUCT DOSE OMISSION IN ERROR 250 0.0088
341 DYSPHONIA 516 0.0088
342 GASTRITIS 232 0.0088
343 WEIGHT DECREASED 2456 0.0088
344 TOOTH DISORDER 195 0.0088
345 CHEST DISCOMFORT 895 0.0087
346 SINUS CONGESTION 118 0.0087
347 DIZZINESS 4356 0.0087
348 EMPHYSEMA 88 0.0087
349 HAEMOGLOBIN ABNORMAL 56 0.0087
350 BONE DISORDER 158 0.0087
351 MICTURITION URGENCY 99 0.0087
352 FAECES SOFT 63 0.0087
353 AGEUSIA 216 0.0087
354 HYPOACUSIS 372 0.0086
355 DECREASED APPETITE 2006 0.0086
356 TENDERNESS 90 0.0086
357 DYSPEPSIA 847 0.0086
358 INTENTIONAL DOSE OMISSION 245 0.0086
359 HIP FRACTURE 276 0.0086
360 INITIAL INSOMNIA 88 0.0086
361 BLOOD COUNT ABNORMAL 130 0.0086
362 BLOOD ALBUMIN DECREASED 68 0.0086
363 PRODUCT SUBSTITUTION ISSUE 492 0.0085
364 VITREOUS FLOATERS 84 0.0085
365 ARTHRITIS 672 0.0085
366 SPINAL FRACTURE 171 0.0085
367 PULMONARY THROMBOSIS 93 0.0085
368 NEUROPATHY PERIPHERAL 810 0.0085
369 FULL BLOOD COUNT ABNORMAL 90 0.0085
370 FATIGUE 6625 0.0085
371 ARTHROPOD BITE 63 0.0085
372 BURSITIS 103 0.0085
373 CLOSTRIDIUM DIFFICILE COLITIS 90 0.0085
374 JOINT INJURY 181 0.0085
375 MUSCULAR WEAKNESS 961 0.0084
376 ANAL INCONTINENCE 76 0.0084
377 SCRATCH 89 0.0084
378 DIARRHOEA 5437 0.0084
379 JOINT EFFUSION 58 0.0084
380 MELAENA 185 0.0084
381 URINARY INCONTINENCE 249 0.0084
382 RECTAL HAEMORRHAGE 360 0.0084
383 DECUBITUS ULCER 68 0.0083
384 SLUGGISHNESS 85 0.0083
385 SINUSITIS 854 0.0083
386 SPUTUM DISCOLOURED 79 0.0083
387 EYE HAEMORRHAGE 111 0.0083
388 SUBDURAL HAEMATOMA 119 0.0083
389 LOCALISED INFECTION 201 0.0083
390 FACIAL PAIN 74 0.0083
391 ORAL CANDIDIASIS 109 0.0083
392 LIMB DISCOMFORT 256 0.0083
393 URINARY RETENTION 276 0.0083
394 ENCEPHALOPATHY 203 0.0083
395 BLADDER DISORDER 82 0.0082
396 COELIAC DISEASE 81 0.0082
397 BACK PAIN 1918 0.0082
398 TOOTH ABSCESS 84 0.0082
399 FLUID OVERLOAD 120 0.0082
400 CATARACT 491 0.0082
401 SCAB 94 0.0082
402 NEPHROLITHIASIS 377 0.0082
403 PNEUMONIA 2660 0.0082
404 DYSURIA 302 0.0082
405 BASAL CELL CARCINOMA 128 0.0082
406 OSTEOPOROSIS 336 0.0082
407 OEDEMA 442 0.0081
408 HAEMATOMA 211 0.0081
409 DENTAL CARIES 90 0.0081
410 CELLULITIS 410 0.0081
411 DIABETES MELLITUS 619 0.0081
412 EXOSTOSIS 74 0.0081
413 DUODENAL ULCER 57 0.0081
414 FLATULENCE 457 0.0081
415 DRY EYE 401 0.0080
416 CEREBROVASCULAR ACCIDENT 1359 0.0080
417 LOW DENSITY LIPOPROTEIN INCREASED 62 0.0080
418 PLATELET COUNT DECREASED 853 0.0080
419 NAIL DISORDER 70 0.0080
420 CANDIDA INFECTION 135 0.0080
421 RENAL DISORDER 372 0.0080
422 RESPIRATION ABNORMAL 55 0.0080
423 CHOLECYSTITIS 95 0.0080
424 EYE INFECTION 90 0.0080
425 INCONTINENCE 84 0.0079
426 URINE OUTPUT DECREASED 69 0.0079
427 DRY MOUTH 639 0.0079
428 SPINAL COMPRESSION FRACTURE 65 0.0079
429 ABDOMINAL DISCOMFORT 1316 0.0078
430 TOOTHACHE 142 0.0078
431 NECK PAIN 438 0.0078
432 ANAEMIA 1491 0.0078
433 GASTROINTESTINAL PAIN 86 0.0078
434 HAEMARTHROSIS 70 0.0078
435 PRODUCT USE COMPLAINT 123 0.0078
436 SPLENOMEGALY 91 0.0078
437 PHARYNGEAL SWELLING 76 0.0078
438 TEMPERATURE INTOLERANCE 80 0.0077
439 INTENTIONAL DRUG MISUSE 162 0.0077
440 MYELODYSPLASTIC SYNDROME 112 0.0077
441 PNEUMONIA BACTERIAL 71 0.0077
442 GASTRIC ULCER 147 0.0077
443 ULCER 123 0.0077
444 POST PROCEDURAL HAEMORRHAGE 90 0.0077
445 UPPER LIMB FRACTURE 154 0.0077
446 PULMONARY ARTERIAL HYPERTENSION 112 0.0077
447 SKIN FISSURES 151 0.0077
448 HALLUCINATION 581 0.0077
449 NASAL CONGESTION 453 0.0077
450 HYPERCALCAEMIA 95 0.0077
451 INTENTIONAL PRODUCT MISUSE 672 0.0077
452 PETECHIAE 80 0.0077
453 TOOTH INFECTION 101 0.0077
454 ECONOMIC PROBLEM 116 0.0076
455 DEMENTIA 213 0.0076
456 CHROMATURIA 172 0.0076
457 POOR QUALITY SLEEP 164 0.0076
458 STAPHYLOCOCCAL INFECTION 251 0.0076
459 KIDNEY INFECTION 149 0.0076
460 PLASMA CELL MYELOMA 296 0.0076
461 GALLBLADDER DISORDER 135 0.0076
462 IRRITABLE BOWEL SYNDROME 162 0.0075
463 HERNIA 146 0.0075
464 DERMATITIS CONTACT 86 0.0075
465 HYPOCALCAEMIA 142 0.0075
466 BLOOD THYROID STIMULATING HORMONE INCREASED 69 0.0075
467 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 127 0.0075
468 SUBARACHNOID HAEMORRHAGE 76 0.0075
469 CHOLELITHIASIS 244 0.0074
470 HALLUCINATION, VISUAL 157 0.0074
471 RESPIRATORY TRACT INFECTION 193 0.0074
472 CEREBRAL HAEMORRHAGE 265 0.0074
473 SPINAL DISORDER 70 0.0074
474 HYPOTHYROIDISM 236 0.0074
475 POST PROCEDURAL INFECTION 60 0.0074
476 CLOSTRIDIUM DIFFICILE INFECTION 161 0.0074
477 GLAUCOMA 142 0.0074
478 SHOCK HAEMORRHAGIC 60 0.0074
479 DRUG INTERACTION 1169 0.0074
480 CONCUSSION 57 0.0074
481 GAIT DISTURBANCE 1409 0.0074
482 FEEDING DISORDER 149 0.0073
483 FEELING COLD 204 0.0073
484 SEPSIS 816 0.0073
485 EAR PAIN 142 0.0073
486 SKIN CANCER 157 0.0073
487 SKIN DISCOLOURATION 335 0.0073
488 RHABDOMYOLYSIS 304 0.0073
489 GINGIVAL PAIN 58 0.0073
490 PLATELET COUNT INCREASED 95 0.0073
491 NERVE INJURY 81 0.0073
492 HEREDITARY ANGIOEDEMA 78 0.0073
493 THROMBOSIS 584 0.0073
494 GAIT INABILITY 242 0.0072
495 HYPOPHAGIA 185 0.0072
496 MEMORY IMPAIRMENT 994 0.0072
497 HYPONATRAEMIA 407 0.0072
498 RENAL IMPAIRMENT 607 0.0072
499 MUSCLE SPASMS 1324 0.0072
500 UNRESPONSIVE TO STIMULI 186 0.0072
501 GENERALISED OEDEMA 89 0.0072
502 OCULAR HYPERAEMIA 341 0.0072
503 LABORATORY TEST ABNORMAL 212 0.0072
504 MUSCLE ATROPHY 91 0.0072
505 MUSCLE STRAIN 62 0.0072
506 TOOTH FRACTURE 79 0.0072
507 MUSCLE DISORDER 58 0.0072
508 COVID-19 1254 0.0071
509 WHITE BLOOD CELL COUNT DECREASED 774 0.0071
510 POST PROCEDURAL COMPLICATION 137 0.0071
511 FOOD ALLERGY 55 0.0071
512 PRODUCT DOSE OMISSION ISSUE 2095 0.0071
513 LACERATION 67 0.0071
514 STOMATITIS 432 0.0071
515 WHITE BLOOD CELL COUNT INCREASED 273 0.0071
516 HAIR TEXTURE ABNORMAL 95 0.0071
517 APHONIA 99 0.0071
518 CHOLECYSTECTOMY 81 0.0071
519 INFLUENZA 790 0.0071
520 BEDRIDDEN 93 0.0071
521 SPINAL OPERATION 87 0.0071
522 VIRAL INFECTION 235 0.0071
523 PAIN IN EXTREMITY 2080 0.0071
524 DYSPHAGIA 670 0.0071
525 CIRCULATORY COLLAPSE 120 0.0070
526 SNEEZING 158 0.0070
527 IMPAIRED HEALING 231 0.0070
528 ILLNESS 724 0.0070
529 SECRETION DISCHARGE 88 0.0070
530 NIGHT SWEATS 226 0.0070
531 TINNITUS 322 0.0070
532 HAIR COLOUR CHANGES 87 0.0070
533 ANKLE FRACTURE 108 0.0070
534 OROPHARYNGEAL PAIN 645 0.0070
535 TRANSFUSION 73 0.0070
536 RHINITIS 56 0.0069
537 COVID-19 PNEUMONIA 82 0.0069
538 CARDIOVASCULAR DISORDER 176 0.0069
539 CARDIAC ARREST 572 0.0069
540 RESPIRATORY FAILURE 505 0.0069
541 GASTROINTESTINAL INFECTION 62 0.0069
542 SLEEP DISORDER 487 0.0069
543 TACHYCARDIA 610 0.0069
544 BLOOD DISORDER 55 0.0069
545 MIDDLE INSOMNIA 128 0.0068
546 NERVOUSNESS 358 0.0068
547 HEPATOMEGALY 67 0.0068
548 DYSSTASIA 199 0.0068
549 LIVER FUNCTION TEST INCREASED 146 0.0068
550 LEUKAEMIA 64 0.0068
551 RESPIRATORY SYNCYTIAL VIRUS INFECTION 59 0.0068
552 FEELING ABNORMAL 1623 0.0068
553 ABDOMINAL DISTENSION 707 0.0068
554 THIRST 121 0.0068
555 CONFUSIONAL STATE 1090 0.0067
556 LOSS OF CONSCIOUSNESS 863 0.0067
557 BLOOD PRESSURE SYSTOLIC INCREASED 131 0.0067
558 RECALLED PRODUCT ADMINISTERED 64 0.0067
559 BONE PAIN 393 0.0067
560 VISION BLURRED 918 0.0067
561 HERPES ZOSTER 384 0.0067
562 MUSCULOSKELETAL PAIN 350 0.0067
563 ASCITES 196 0.0067
564 DELUSION 103 0.0066
565 PRESCRIBED UNDERDOSE 132 0.0066
566 SQUAMOUS CELL CARCINOMA 62 0.0066
567 OSTEOMYELITIS 119 0.0066
568 BLOOD GLUCOSE FLUCTUATION 72 0.0066
569 INSOMNIA 1748 0.0066
570 CHOKING 128 0.0066
571 ORAL DISCOMFORT 91 0.0065
572 MYALGIA 1112 0.0065
573 DEVICE OCCLUSION 92 0.0065
574 MASS 91 0.0065
575 LETHARGY 374 0.0065
576 PNEUMOTHORAX 103 0.0065
577 DRY THROAT 66 0.0065
578 EYE SWELLING 241 0.0065
579 NAUSEA 5124 0.0065
580 HYPOAESTHESIA ORAL 97 0.0064
581 DIPLOPIA 167 0.0064
582 DEAFNESS 168 0.0064
583 APHASIA 194 0.0064
584 NASOPHARYNGITIS 1182 0.0064
585 COLD SWEAT 113 0.0064
586 ASPIRATION 70 0.0064
587 HEADACHE 4007 0.0064
588 BLOOD GLUCOSE ABNORMAL 118 0.0064
589 SCAR 109 0.0064
590 VERTIGO 387 0.0063
591 ABDOMINAL PAIN UPPER 1299 0.0063
592 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 303 0.0063
593 DEEP VEIN THROMBOSIS 409 0.0063
594 SARS-COV-2 TEST POSITIVE 83 0.0063
595 ELECTROCARDIOGRAM QT PROLONGED 226 0.0063
596 THINKING ABNORMAL 117 0.0063
597 ANHEDONIA 165 0.0063
598 BLOOD TEST ABNORMAL 88 0.0063
599 QUALITY OF LIFE DECREASED 84 0.0063
600 FEELING JITTERY 119 0.0062
601 IMMUNODEFICIENCY 93 0.0062
602 RASH PRURITIC 338 0.0062
603 RASH MACULAR 218 0.0062
604 KNEE ARTHROPLASTY 131 0.0062
605 IMMUNE SYSTEM DISORDER 82 0.0062
606 SKIN SWELLING 54 0.0062
607 EYE PRURITUS 209 0.0062
608 FIBROMYALGIA 151 0.0062
609 BLOOD ALKALINE PHOSPHATASE INCREASED 154 0.0062
610 METABOLIC ACIDOSIS 198 0.0062
611 UNEVALUABLE EVENT 468 0.0062
612 POLYNEUROPATHY 74 0.0062
613 THERAPY INTERRUPTED 440 0.0062
614 FOOT DEFORMITY 68 0.0061
615 HYPOAESTHESIA 918 0.0061
616 THERAPEUTIC RESPONSE UNEXPECTED 275 0.0061
617 HYPOTHERMIA 62 0.0061
618 HYPERGLYCAEMIA 223 0.0061
619 DYSGEUSIA 454 0.0061
620 DISORIENTATION 242 0.0061
621 PULMONARY FIBROSIS 117 0.0061
622 FUNGAL INFECTION 203 0.0061
623 NEURALGIA 148 0.0061
624 HYPERTHYROIDISM 88 0.0061
625 THERAPY NON-RESPONDER 273 0.0061
626 SKIN INFECTION 68 0.0061
627 SPINAL PAIN 71 0.0061
628 EATING DISORDER 129 0.0061
629 DRUG DOSE OMISSION 999 0.0060
630 MUSCULOSKELETAL DISORDER 115 0.0060
631 SURGERY 354 0.0060
632 METASTASES TO BONE 99 0.0060
633 FLUSHING 613 0.0060
634 WHEEZING 357 0.0060
635 TREMOR 998 0.0060
636 TREATMENT NONCOMPLIANCE 328 0.0060
637 HYPOKINESIA 87 0.0060
638 DIALYSIS 85 0.0060
639 BLISTER 336 0.0060
640 WEIGHT INCREASED 1339 0.0060
641 SKIN LESION 164 0.0060
642 HYPERHIDROSIS 768 0.0060
643 TACHYPNOEA 81 0.0060
644 NEUTROPHIL COUNT INCREASED 61 0.0060
645 AUTOIMMUNE DISORDER 58 0.0059
646 RENAL PAIN 63 0.0059
647 ISCHAEMIC STROKE 106 0.0059
648 DEPRESSION 1349 0.0059
649 METASTASES TO LIVER 104 0.0059
650 ARTHRALGIA 2458 0.0059
651 PRODUCT TASTE ABNORMAL 80 0.0059
652 PRURITUS 2266 0.0059
653 APATHY 86 0.0059
654 IMPAIRED DRIVING ABILITY 67 0.0059
655 HIP ARTHROPLASTY 90 0.0059
656 FEAR 158 0.0059
657 SPEECH DISORDER 307 0.0059
658 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1055 0.0058
659 DISCOMFORT 357 0.0058
660 RESTLESSNESS 214 0.0058
661 ANXIETY 1663 0.0058
662 GASTROENTERITIS 85 0.0058
663 BURNING SENSATION 408 0.0058
664 CYST 72 0.0058
665 CYTOPENIA 71 0.0058
666 LUNG DISORDER 284 0.0058
667 EAR INFECTION 154 0.0058
668 HAEMORRHAGE 601 0.0057
669 MALAISE 2516 0.0057
670 LOWER LIMB FRACTURE 110 0.0057
671 DEVICE RELATED INFECTION 88 0.0057
672 PRODUCT DOSE OMISSION 373 0.0057
673 VISUAL IMPAIRMENT 706 0.0057
674 SWELLING 533 0.0057
675 GASTROINTESTINAL DISORDER 510 0.0057
676 NIGHTMARE 197 0.0057
677 KNEE OPERATION 56 0.0057
678 AMNESIA 369 0.0057
679 JOINT RANGE OF MOTION DECREASED 76 0.0057
680 SOMNOLENCE 1140 0.0057
681 GASTRIC HAEMORRHAGE 65 0.0056
682 DRY SKIN 748 0.0056
683 LYMPHOCYTE COUNT DECREASED 99 0.0056
684 MADAROSIS 65 0.0056
685 HAEMATOCHEZIA 309 0.0056
686 MALIGNANT MELANOMA 75 0.0056
687 ARTHROPATHY 311 0.0056
688 ALOPECIA 1096 0.0056
689 LACTIC ACIDOSIS 180 0.0056
690 METASTASES TO LUNG 64 0.0055
691 SWOLLEN TONGUE 173 0.0055
692 DIABETES MELLITUS INADEQUATE CONTROL 98 0.0055
693 DELIRIUM 192 0.0055
694 MUSCLE TIGHTNESS 89 0.0055
695 HEMIPARESIS 93 0.0055
696 MOBILITY DECREASED 394 0.0055
697 CHILLS 642 0.0055
698 PNEUMONITIS 149 0.0055
699 PULMONARY EMBOLISM 520 0.0055
700 LIVER FUNCTION TEST ABNORMAL 159 0.0055
701 BACTERIAL INFECTION 102 0.0055
702 TOOTH EXTRACTION 68 0.0055
703 GASTRIC DISORDER 187 0.0054
704 PRODUCT AVAILABILITY ISSUE 124 0.0054
705 MENTAL IMPAIRMENT 132 0.0054
706 PRODUCT ADMINISTRATION ERROR 110 0.0054
707 INABILITY TO AFFORD MEDICATION 54 0.0054
708 MULTI-ORGAN FAILURE 94 0.0054
709 BLOOD GLUCOSE DECREASED 261 0.0054
710 HEPATIC CIRRHOSIS 102 0.0054
711 ROAD TRAFFIC ACCIDENT 226 0.0054
712 ACCIDENT 64 0.0054
713 PAIN 3289 0.0053
714 VOMITING 2508 0.0053
715 DRUG EFFECT LESS THAN EXPECTED 79 0.0053
716 RESPIRATORY DISTRESS 147 0.0053
717 PANIC ATTACK 193 0.0053
718 JOINT SWELLING 639 0.0053
719 DYSARTHRIA 199 0.0053
720 HAEMATEMESIS 134 0.0053
721 SEPTIC SHOCK 230 0.0053
722 ASTHMA 597 0.0053
723 TENDON RUPTURE 65 0.0053
724 RASH 2294 0.0053
725 ACTIVITIES OF DAILY LIVING IMPAIRED 104 0.0052
726 HEPATIC ENZYME INCREASED 358 0.0052
727 SKIN EXFOLIATION 443 0.0052
728 PARALYSIS 75 0.0052
729 COLON CANCER 78 0.0052
730 INCREASED APPETITE 100 0.0052
731 ILEUS 65 0.0052
732 PANCYTOPENIA 292 0.0052
733 ASPARTATE AMINOTRANSFERASE INCREASED 277 0.0052
734 BLOOD GLUCOSE INCREASED 979 0.0052
735 HYPOGLYCAEMIA 252 0.0052
736 ABNORMAL DREAMS 143 0.0052
737 PHARYNGITIS STREPTOCOCCAL 56 0.0052
738 LYMPHADENOPATHY 183 0.0052
739 LUNG INFECTION 80 0.0051
740 INTENTIONAL PRODUCT USE ISSUE 451 0.0051
741 ERECTILE DYSFUNCTION 132 0.0051
742 BACTERAEMIA 61 0.0051
743 DISTURBANCE IN ATTENTION 277 0.0051
744 PRURITUS GENERALISED 111 0.0051
745 CEREBRAL INFARCTION 125 0.0051
746 GLOSSODYNIA 114 0.0051
747 INJECTION SITE NODULE 56 0.0051
748 ADVERSE DRUG REACTION 454 0.0050
749 PARAESTHESIA 792 0.0050
750 PANCREATITIS ACUTE 113 0.0050
751 COLITIS 190 0.0050
752 BLOOD BILIRUBIN INCREASED 135 0.0050
753 PRODUCT USE ISSUE 939 0.0050
754 PRODUCT USE IN UNAPPROVED INDICATION 1238 0.0050
755 JOINT STIFFNESS 131 0.0050
756 INFECTION 720 0.0050
757 PHOTOSENSITIVITY REACTION 82 0.0050
758 FEELING HOT 304 0.0050
759 HUNGER 69 0.0049
760 OFF LABEL USE 4336 0.0049
761 COORDINATION ABNORMAL 69 0.0049
762 THERAPY PARTIAL RESPONDER 77 0.0049
763 DEVICE FAILURE 75 0.0049
764 COGNITIVE DISORDER 229 0.0049
765 WOUND 137 0.0049
766 DRUG INTOLERANCE 472 0.0049
767 MUSCLE SPASTICITY 60 0.0049
768 GLYCOSYLATED HAEMOGLOBIN INCREASED 123 0.0049
769 SKIN DISORDER 162 0.0049
770 THROMBOCYTOPENIA 543 0.0049
771 PROTEINURIA 92 0.0048
772 BRONCHOSPASM 69 0.0048
773 SWELLING FACE 314 0.0048
774 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 343 0.0048
775 PANCREATITIS 254 0.0048
776 BODY TEMPERATURE INCREASED 98 0.0048
777 PARAESTHESIA ORAL 69 0.0048
778 EYE DISORDER 157 0.0048
779 THERAPY CESSATION 244 0.0047
780 BLINDNESS UNILATERAL 67 0.0047
781 ADVERSE EVENT 437 0.0047
782 ABDOMINAL PAIN 1093 0.0047
783 FEMUR FRACTURE 145 0.0047
784 INJURY 328 0.0047
785 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 256 0.0047
786 PRODUCT PHYSICAL ISSUE 94 0.0047
787 HALLUCINATION, AUDITORY 74 0.0047
788 RESPIRATORY DISORDER 139 0.0046
789 ECZEMA 243 0.0046
790 DEPRESSED MOOD 245 0.0046
791 PALLOR 126 0.0046
792 INJECTION SITE EXTRAVASATION 57 0.0046
793 PHARYNGITIS 57 0.0046
794 INTESTINAL OBSTRUCTION 173 0.0046
795 DERMATITIS 96 0.0046
796 ANOREXIA 59 0.0046
797 MUSCULOSKELETAL STIFFNESS 401 0.0046
798 LIP SWELLING 152 0.0046
799 ATAXIA 54 0.0045
800 ALANINE AMINOTRANSFERASE INCREASED 279 0.0045
801 BLOOD LACTATE DEHYDROGENASE INCREASED 72 0.0045
802 DRUG LEVEL INCREASED 75 0.0045
803 PNEUMONIA ASPIRATION 113 0.0045
804 NODULE 59 0.0045
805 CONDITION AGGRAVATED 1374 0.0045
806 NEOPLASM PROGRESSION 157 0.0045
807 NO THERAPEUTIC RESPONSE 55 0.0045
808 HOSPITALISATION 693 0.0045
809 PHARYNGEAL OEDEMA 69 0.0045
810 MULTIPLE ORGAN DYSFUNCTION SYNDROME 127 0.0045
811 SHOCK 103 0.0045
812 DERMATITIS ATOPIC 236 0.0045
813 INFLUENZA LIKE ILLNESS 368 0.0045
814 TRANSAMINASES INCREASED 99 0.0044
815 CYANOSIS 70 0.0044
816 DISABILITY 88 0.0044
817 BLOOD CREATINE PHOSPHOKINASE INCREASED 126 0.0044
818 CARDIO-RESPIRATORY ARREST 183 0.0044
819 DERMATITIS ALLERGIC 55 0.0044
820 ABDOMINAL PAIN LOWER 110 0.0043
821 ABASIA 107 0.0043
822 HYPERSENSITIVITY 802 0.0043
823 MENTAL DISORDER 188 0.0043
824 SENSORY DISTURBANCE 69 0.0043
825 MUSCLE TWITCHING 99 0.0043
826 MIGRAINE 408 0.0043
827 PRODUCT PRESCRIBING ISSUE 93 0.0043
828 MOVEMENT DISORDER 137 0.0043
829 MULTIPLE FRACTURES 70 0.0043
830 GENERAL PHYSICAL HEALTH DETERIORATION 492 0.0042
831 DEATH 3613 0.0042
832 METASTASES TO CENTRAL NERVOUS SYSTEM 54 0.0042
833 NEUTROPHIL COUNT DECREASED 169 0.0041
834 CONTRAINDICATED PRODUCT ADMINISTERED 125 0.0041
835 LIVER DISORDER 183 0.0041
836 FREQUENT BOWEL MOVEMENTS 111 0.0041
837 THERAPEUTIC RESPONSE SHORTENED 136 0.0041
838 CONJUNCTIVITIS 76 0.0041
839 COMPLICATION ASSOCIATED WITH DEVICE 59 0.0041
840 DYSKINESIA 165 0.0041
841 PRODUCT QUALITY ISSUE 551 0.0041
842 OSTEONECROSIS OF JAW 100 0.0040
843 RASH ERYTHEMATOUS 193 0.0040
844 PYREXIA 1394 0.0040
845 SEIZURE 464 0.0040
846 VISUAL ACUITY REDUCED 133 0.0040
847 BLINDNESS 163 0.0040
848 DISEASE RECURRENCE 190 0.0040
849 ERYTHEMA 819 0.0040
850 HEPATIC FAILURE 120 0.0040
851 DRUG TOXICITY 54 0.0040
852 LOCAL SWELLING 69 0.0040
853 ORAL HERPES 77 0.0039
854 DRUG DISPENSING ERROR 60 0.0039
855 NEOPLASM MALIGNANT 262 0.0039
856 DRUG-INDUCED LIVER INJURY 123 0.0039
857 ACUTE RESPIRATORY DISTRESS SYNDROME 69 0.0039
858 INJECTION SITE MASS 144 0.0039
859 ACUTE HEPATIC FAILURE 53 0.0039
860 URTICARIA 644 0.0038
861 RASH PAPULAR 86 0.0038
862 TOXICITY TO VARIOUS AGENTS 646 0.0038
863 ACCIDENTAL OVERDOSE 139 0.0038
864 LEUKOPENIA 190 0.0038
865 LUNG NEOPLASM MALIGNANT 156 0.0038
866 PAIN OF SKIN 102 0.0038
867 DEVICE USE ISSUE 66 0.0038
868 TOOTH LOSS 78 0.0038
869 INFLAMMATION 194 0.0038
870 FRACTURE 71 0.0037
871 PROCEDURAL PAIN 104 0.0037
872 CYTOKINE RELEASE SYNDROME 75 0.0037
873 AGITATION 273 0.0037
874 PARANOIA 64 0.0037
875 EXPOSURE VIA SKIN CONTACT 96 0.0037
876 ABSCESS 59 0.0037
877 THROAT TIGHTNESS 100 0.0037
878 TENDONITIS 57 0.0037
879 PSORIATIC ARTHROPATHY 149 0.0037
880 RASH GENERALISED 95 0.0037
881 ANGIOEDEMA 161 0.0036
882 THERAPEUTIC PRODUCT EFFECT DECREASED 163 0.0036
883 MALIGNANT NEOPLASM PROGRESSION 371 0.0036
884 THERAPEUTIC RESPONSE DECREASED 219 0.0036
885 DRUG EFFECT INCOMPLETE 131 0.0036
886 ILL-DEFINED DISORDER 217 0.0036
887 GAMMA-GLUTAMYLTRANSFERASE INCREASED 79 0.0036
888 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 83 0.0036
889 DISEASE PROGRESSION 416 0.0035
890 PRODUCT PRESCRIBING ERROR 83 0.0035
891 RHEUMATOID ARTHRITIS 394 0.0035
892 INCORRECT DOSE ADMINISTERED 791 0.0035
893 ACUTE MYELOID LEUKAEMIA 54 0.0035
894 STEVENS-JOHNSON SYNDROME 77 0.0035
895 DEPRESSED LEVEL OF CONSCIOUSNESS 137 0.0035
896 FACE OEDEMA 58 0.0034
897 UNDERDOSE 250 0.0034
898 INJECTION SITE PRURITUS 227 0.0034
899 DRUG PRESCRIBING ERROR 65 0.0034
900 COMA 161 0.0034
901 C-REACTIVE PROTEIN INCREASED 123 0.0034
902 DRUG INEFFECTIVE 4420 0.0034
903 PRODUCT DISPENSING ERROR 73 0.0033
904 MOOD ALTERED 91 0.0033
905 FEBRILE NEUTROPENIA 221 0.0033
906 PSORIASIS 433 0.0033
907 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 670 0.0033
908 RESPIRATORY ARREST 90 0.0033
909 CRYING 115 0.0032
910 NEUTROPENIA 425 0.0031
911 JAUNDICE 84 0.0031
912 PSYCHOTIC DISORDER 92 0.0031
913 MEDICATION ERROR 173 0.0031
914 INJECTION SITE RASH 95 0.0031
915 EXTRA DOSE ADMINISTERED 125 0.0031
916 ABNORMAL BEHAVIOUR 121 0.0031
917 INCORRECT PRODUCT ADMINISTRATION DURATION 66 0.0030
918 INJECTION SITE URTICARIA 74 0.0030
919 LIVER INJURY 74 0.0030
920 EMOTIONAL DISTRESS 363 0.0030
921 MOUTH ULCERATION 63 0.0030
922 INJECTION SITE BRUISING 236 0.0030
923 EMOTIONAL DISORDER 91 0.0029
924 MUCOSAL INFLAMMATION 77 0.0029
925 ANAPHYLACTIC REACTION 162 0.0029
926 IRRITABILITY 175 0.0029
927 DRUG EFFECT DECREASED 155 0.0029
928 DIABETIC KETOACIDOSIS 69 0.0029
929 INFUSION RELATED REACTION 190 0.0029
930 NERVOUS SYSTEM DISORDER 89 0.0028
931 WRONG TECHNIQUE IN DRUG USAGE PROCESS 103 0.0028
932 PRESCRIBED OVERDOSE 54 0.0028
933 NEEDLE ISSUE 81 0.0028
934 INJECTION SITE SWELLING 213 0.0028
935 EXPIRED PRODUCT ADMINISTERED 92 0.0028
936 DEVICE ISSUE 248 0.0028
937 DRUG ADMINISTRATION ERROR 84 0.0027
938 MOOD SWINGS 87 0.0027
939 INJECTION SITE ERYTHEMA 338 0.0027
940 SYSTEMIC LUPUS ERYTHEMATOSUS 96 0.0027
941 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 192 0.0027
942 PHARMACEUTICAL PRODUCT COMPLAINT 70 0.0027
943 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 90 0.0027
944 INJECTION SITE PAIN 816 0.0027
945 INTERSTITIAL LUNG DISEASE 128 0.0026
946 IMPAIRED WORK ABILITY 56 0.0026
947 DEVICE MALFUNCTION 183 0.0026
948 COMPLETED SUICIDE 216 0.0026
949 INJECTION SITE HAEMORRHAGE 206 0.0026
950 RASH MACULO-PAPULAR 57 0.0026
951 HEPATIC FUNCTION ABNORMAL 95 0.0025
952 HEPATITIS 65 0.0025
953 SEDATION 66 0.0025
954 HEPATOTOXICITY 56 0.0025
955 SUICIDE ATTEMPT 152 0.0025
956 PANCREATIC CARCINOMA 72 0.0025
957 MULTIPLE SCLEROSIS 116 0.0024
958 ANGER 82 0.0024
959 DEVICE LEAKAGE 105 0.0024
960 VAGINAL HAEMORRHAGE 104 0.0024
961 MULTIPLE SCLEROSIS RELAPSE 164 0.0024
962 SUICIDAL IDEATION 214 0.0023
963 BREAST CANCER FEMALE 62 0.0023
964 AGGRESSION 114 0.0023
965 CONVULSION 130 0.0023
966 BONE DENSITY DECREASED 71 0.0023
967 WITHDRAWAL SYNDROME 92 0.0022
968 INTENTIONAL OVERDOSE 140 0.0022
969 INJECTION SITE REACTION 144 0.0021
970 EXPOSURE DURING PREGNANCY 130 0.0021
971 ACNE 155 0.0020
972 BREAST CANCER 187 0.0020
973 SKIN IRRITATION 90 0.0020
974 OVERDOSE 423 0.0020
975 EPILEPSY 56 0.0018
976 SKIN BURNING SENSATION 131 0.0018
977 DEVICE DISLOCATION 79 0.0018
978 OSTEONECROSIS 58 0.0018
979 LOWER RESPIRATORY TRACT INFECTION 80 0.0018
980 ACCIDENTAL EXPOSURE TO PRODUCT 180 0.0017
981 PROSTATE CANCER 139 0.0017
982 COLITIS ULCERATIVE 76 0.0017
983 FOETAL EXPOSURE DURING PREGNANCY 134 0.0016
984 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 76 0.0016
985 NO ADVERSE EVENT 276 0.0015
986 PRODUCT STORAGE ERROR 115 0.0013
987 DRUG WITHDRAWAL SYNDROME 109 0.0012
988 BLADDER CANCER 72 0.0012
989 DEVICE DIFFICULT TO USE 78 0.0012
990 MATERNAL EXPOSURE DURING PREGNANCY 98 0.0011
991 TREATMENT FAILURE 90 0.0011
992 DRUG ABUSE 85 0.0010
993 DRUG DEPENDENCE 90 0.0006